Insulin-like growth factor-1, psoriasis, and inflammation: A ménage à trois?

European Journal of Inflammation

Volumn 9, Issue 3, 2011, Pages 277-283

  Savastano, S ^a   Balato, N ^a   Gaudiello, F ^a   Di Somma, C ^b   Brancato, V ^a   Colao, A ^a   Ayala, F ^a   Tarantino, Giovanni ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b IRCCS SDN   (Italy)

Author keywords

IGF I; Inflammation; Metabolic syndrome; Psoriasis; Visceral adiposity index

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 6; SOMATOMEDIN C;

ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PSORIASIS; PSORIASIS AREA AND SEVERITY INDEX; PSORIASIS SEVERITY INDEX; SKIN DISEASE; WAIST CIRCUMFERENCE;

EID: 84858691206     PISSN: 1721727X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1721727X1100900308     Document Type: Article

References (25)

1. Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and therapy of psoriasis. Nature 2007; 22:866-73.
2. Davidovici BB, Sattar N, Prinz JC, et al. Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. J Invest Dermatol 2010; 130:1785-96.
3. Gerdes S, Zahl VA, Knopf H, Weichenthal M, Mrowietz U. Comedication related to comorbidities: a study in 1203 hospitalized patients with severe psoriasis. Br J Dermatol 2008; 159:1116-23.
4. Bongiorno MR, Doukaki S, Rizzo D, Arico M. The prevalence of the obesity in patients with moderate to severe psoriasis in Sicily populations. J Eur Acad Dermatol Venereol 2010; 24:92-3.
5. Love TJ, Qureshi AA, Karlson EW, Gelfand JM, Choi HK. Prevalence of the Metabolic Syndrome in Psoriasis. Arch Dermatol 2011; 147:419-24.
6. von Laue S, Ross RJ. Inflammatory cytokines and acquired growth hormone resistance. Growth Horm IGF Res 2000; 10(S):9-14.
7. Miura H, Sano S, Higashiyama M, Yoshikawa K, Itami S. Involvement of insulin-like growth factor-I in psoriasis as a paracrine growth factor: dermal fibroblasts play a regulatory role in developing psoriatic lesions. Arch Dermatol Res 2000; 292:590-7. (Pubitemid 32112966)
8. Barreca A, De Luca M, Del Monte P, et al. In vitro paracrine regulation of human keratinocyte growth by fibroblast-derived insulin-like growth factors. J Cell Physiol 1992; 151:262-8.
9. Krane JF, Gottlieb AB, Carter DM, Krueger JG. The insulin-like growth factor I receptor is overexpressed in psoriatic epidermis, but is differentially regulated from the epidermal growth factor receptor. J EXp Med 1996; 175:1081-90.
10. Damasiewicz-Bodzek A, Kos-Kudła B, Suwała-Jurczyk B. Somatotrophin axis hormones in patients affected with psoriasis. Neuro Endocrinol Lett 2005; 26:724-28.
11. Yeap BB, Chubb SA, Ho KK, Hankey GJ, Norman PE, Flicker L. Associations of IGF1 and IGFBPs 1 and 3 with all-cause and cardiovascular mortality in older men: the Health In Men Study. Eur J Endocrinol 2011; 164:715-23.
12. O'Connor JC, McCusker RH, Strle K, Johnson RW, Dantzer R, Kelley KW. Regulation of IGF-I function by proinflammatory cytokines: at the interface of immunology and endocrinology. Cell Immunol 2008; 252:91-110.
13. Colao A, Di Somma C, Cascella T, Pivonello R, Vitale G, Grasso LF, Lombardi G, Savastano S. Relationships between serum IGF1 levels, blood pressure, and glucose tolerance: an observational, exploratory study in 404 subjects. Eur J Endocrinol 2008; 159:389-97.
14. National Institute of Health. Third report of the National Cholesterol Education Program Export Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Executive Summary. NIH publ. no. 01-3670. Bethesda, MD: National Institute of Health, National Heart, Lung and Blood Institute, 2001.
15. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412-9. (Pubitemid 15018832)
16. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999; 22:1462-70. (Pubitemid 29418240)
17. Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M, Galluzzo A; AlkaMeSy Study Group. Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010; 33:920-22.
18. Roubenoff R. Catabolism of aging: is it an inflammatory process? Curr Opin Clin Nutr Metab Care 2003; 6:295-99. (Pubitemid 40684606)
19. Juul A. Serum levels of insulin-like growth factor I and its binding proteins in health and disease. Growth Horm IGF Res 2003; 13:113-70. (Pubitemid 36986557)
20. Amato MC, Giordano C, Pitrone M, Galluzzo A. Cut-off points of the visceral adiposity index (VAI) identifying a visceral adipose dysfunction associated with cardiometabolic risk in a Caucasian Sicilian population. Lipids Health Dis 2011; 10:183.
21. Sandhu MS. Insulin-like growth factor-I and risk of type 2 diabetes and coronary heart disease: molecular epidemiology. Endocr Dev 2005; 9:44-54.
22. van Bunderen CC, van Nieuwpoort IC, van Schoor NM, Deeg DJ, Lips P, Drent ML. The association of serum insulin-like growth factor-I with mortality, cardiovascular disease, and cancer in the elderly: a population-based study. J Clin Endocrinol Metab 2010; 95:4616-24.
23. Gatenby VK, Kearney MT. The role of IGF-I resistance in obesity and type 2 diabetes-mellitus-related insulin resistance and vascular disease. Expert Opin Ther Targets 2010; 14:1333-42.
24. Conti E, Musumeci MB, De Giusti M, Dito E, Mastromarino V, Autore C, Volpe M IGF-1 and atherothrombosis: relevance to pathophysiology and therapy Clin Sci (Lond) 2011; 120:377-402.
25. Street ME, Spaggiari C, Volta C, Ziveri MA, Viani I, Rossi M, Pisi G, Grzincich G, Bernasconi S. The IGF system and cytokine interactions and relationships with longitudinal growth in prepubertal patients with cystic fibrosis. Clin Endocrinol (Oxf) 2009; 70:593-98.